2023 Speakers
David Aanensen, Director, Centre for Genomic Pathogen Surveillance
Kim Abbass, Clinical Coordinator Antimicrobial Stewardship and Pharmacy Practice, Eastern Zone,, Nova Scotia Health
Mark Albrecht, Branch Chief - Antibacterials Program, BARDA
Jose Alexander, Clinical Microbiologist, Director of Microbiology, Virology & Immunology, Advent Health
Fred Innocent Alih, Senior Health Manager, International Rescue Committee
Yewande Alimi, AMR & One Health Program Coordinator, Africa CDC
Arielle Allen, Project Firstline Infection Preventionist, Pennsylvania Department of Health
Najy Alsayed, Global Therapeutic Area Head - Infectious Diseases Menarini Group, Menarini Group
John Alter, Head of External Affairs, AMR Action Fund
Craig Altier, Professor of Population Medicine & Diagnsostic Sciences, Weill Cornell Medicine
Javad Aman, President and Chief Scientific Officer, AbVacc Inc.
Kensey Amaya, Project Officer, HHS/ASPR/BARDA
James Anderson, Executive Director, Global Health, IFPMA
Ruth Appleby, Senior Alliance Manager, CARB-X
Phyllis Arthur, Vice President, Infectious Diseases and Diagnostics Policy, Biotechnology Innovation Organization (BIO)
Ella Balasa, Patient Advocate, ---
Hend Barry, Lead Clinical Pharmacist, Emergency Medicine Clincial Pharmacist, Swedish Medical Center
Priya Basu, Executive Head, The Pandemic Fund Secretariat, The World Bank
Carolina Batista, Member of DNDi Access Committee, DNDi
Christoph Bausch, Executive Vice President & Chief Operating Officer, SAb Biotherapeutics Inc
Ana Isabel Bento, Director of Science, The Rockefeller Foundation
Silvia Bertagnolio, Unit Head of Antimicrobial Resistance, World Health Organization
Peter Beyer, Deputy Executive Director, GARDP
Alexandra Bhatti, Director of U.S. Vaccine Public Policy, Merck
Nagesh Borse, Deputy Chief Health Officer, Project HOPE
Maria Bottazzi, Professor and Codirector Texas Children's Center for Vaccine Developement, Baylor College of Medicine
Rick Bright, Founder, Bright Global Health
Juliane Bubeck-Wardenburg, Professor of Pediatrics and Chief, Washington University School of Medicine in St. Louis
Kee Kee Buckley, Filmmaker, Writer, Advocate & C. diff Survivor
Paul Burton, CMO, Moderna
Ed Buurman, Director Alliances, CARB-X
Katy Capers, Associate Director for Communication, Division of Healthcare Quality Promotion, CDC
Francesca Chiara, Director of Antimicrobial Resistance Stewardship, Center for Infectious Disease Research & Policy (CIDRAP)
Megan Coffee, Communicable Diseases Advisor, International Rescue Committee
Jennifer Cohn, Director, Global Access, Global Antibiotic Research & Development Partnership (GARDP)
Isabel Colbourn, Series Producer, BBC StoryWorks Programme Partnerships
Alexandre Costa, Senior Health Advisor, UNICEF
Angela Coulliette-Salmond, Lead – Healthcare Wastewater Team, CDC
Nick Crabb, Programme Director, Scientific Affairs, National Institute for Health and Care Excellence
Michael Craig, Senior Advisor for Antimicrobial Resistance, Antimicrobial Resistance Coordination and Strategy Unit, Centers for Disease Control and Prevention
Andrea Crisanti, Professor of Molecular Parisitology, Imperial College London
Kathy E. Currie, PharmD, BCPS, Clinical Pharmacist, Providence Regional Medical Center Everett
Natalie D'Amore, Head of External Innovation, Seres Therapeutics Inc
Demetre Daskalakis, Director for the Division of HIV Prevention & Former Deputy Coordinator National Mpox Response, CDC
Matthew Davenport, Project Officer, HHS/OS/ASPR/BARDA
Damiano de Felice, Director of Development and External Engagement, CARB-X
César De La Fuente, Presidential Assistant Professor, University of Pennsylvania
Robert Deluccia, Executive Chairman, Acurx Pharmaceuticals
Erica DeWald, Chief Communiation Officer, Vaccinate Your Family
Erin Duffy, Chief of Research & Development, CARB-X
Alan Dunton, Non-Executive Director, Recce Pharmaceuticals
Paul Eder, Senior Scientific Officer, National Institutes of Health
Erika Edwards, Health and Medical Reporter and Writer, NBC News
Abiodun Egwuenu, Programme Manager - AMR, Nigeria Centre for Disease Control
Aleks Engel, Director, REPAIR Impact Fund, Novo Holdings
Nada Fadul, Professor - Division of Infectious Diseases & Assistant Dean for Diversity, Equity, and Inclusion (DEI) Education Programs, University of Nebraska Medical Center
Victoria Fan, Senior Fellow, Center for Global Development
Richard Feiner, Academic Member, Columbia University
Cecilia Ferreyra, Head AMR Programme, FIND
Yann Ferrisse, Director, Business Development & Partner Engagement, GARDP
Lynn Filpi, Assistant Director for One Health and Antimicrobial Resistance, Office of Science and Technology Policy – Executive Office of the President
Jason Gale, Senior Editor and Biosecurity Correspondent, Bloomberg News
Hayley Gans, Director of Pediatric Infectious Diseases Program for Immunocompromised Host, Stanford University Medical Center
Jay Garland, Division Director, United States Environmental Protection Agency
Bruce Gellin, Chief, Global Public Health Strategy, The Rockefeller Foundation
Volker Gerdts, Director and Chief Executive Officer, VIDO
Valeria Gigante, Team Lead, World Health Organization
Margaret Gilman, Manager, Infection Prevention and Control, Nemours Children’s Hospital, Delaware
James Graham, Chief Executive Officer, Recce Pharmaceuticals
Malin Grape, Ambassador on Antimicrobial Resistance, Ministry of Health & Social Affairs
David Greenberg, Professor of Infectious Diseases and Microbiology, UT Southwestern Medical Center
Amy Groom, Director of Immunization Initiatives, University of New Mexico Health Sciences Center, ECHO Institute
Philippe Guibert, Council Chairman, International Corporate Health Leadership Council
Javier Guzman, Director, Global Health Policy, Center for Global Development
Janet Haas, Assoicate Editor, American Journal of Infection Control
Douglas Häggström, Management Team, INCATE
Celina Hanson, Global Health & Immunization Specialist, UNICEF
Bud O'Neil Harris, Medical Director of Research, Our Lady of the Lake Regional Medical Center in Baton Rouge
Kathleen Hefferon, Instructor of Microbiology, Cornell University
Martin Heidecker, Chief Investment Officer, AMR Action Fund
Matthew Henn, Chief Scientific Officer, Seres Therapeutics Inc
Thomas Heymann, President and Chief Executive Officer, Sepsis Alliance
Peter Hotez, Dean, National School Of Tropical Medicine, Co-Director, Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine
Teri Hulett, Founder, Infection Prevention Strategies, LLC
Sujith J Chandy, Executive Director, International Centre for AMR solutions (ICARS)
John Jernigan, Chief, Epidemiology Research, and Innovations Branch, Centers for Disease Control and Prevention
Amanda Jezek, Senior Vice President, Public Policy And Government Relations, Infectious Diseases Society of America
Kris Johansen, Associate Director of External Relations, National Institute of Antimicrobial Resistance Research and Education (NIAMMRE)
Mark Jones, Head of Development, Basilea Pharmaceutica Ltd
Devin Jopp, Chief Executive Officer, APIC
Tina Joshi, Associate Professor in Molecular Microbiology, University of Plymouth
Claudine Kabera, Epidemiologist, FDA
Amy Karachalios, Infection Preventionist, Main Line Health
Rajendra Kasinath, Principal Scientist, Johnson & Johnson
Marcy Kelly, Dean School of Science, Manhattan College
Kamran Khan, Founder & CEO, Bluedot
Riko Kimoto, Senior Project Manager, Asia-Europe Foundation
Amy Kirby, Microbiologist, Waterborne Disease Prevention Branch Dfwed-Ncezid, CDC
Rogers Kisame, Program Manager - Health Security, Baylor College of Medicine Children's Foundation Uganda
Harry Kleanthous, Executive Vice President, Vaccines R&D Strategy & External Innovation, SK bioscience
Jeremy Knox, Head of Policy and Infectious Diseases, Wellcome Trust
Akhila Kosaraju, Chief Executive Officer and President, Phare Bio
Melanie Kremer, Assistant Chief, Infection Prevention & Control, James A. Haley Veterans' Hospital and Clinics
Michelle Kromm, Principal, Food Forward LLC
Arun Kumar, Vaccine Development Lead, CEPI
Niranjan Kumar, President & Chief Executive Officer, ABS Inc. USA
Eve Lackritz, Deputy Director, Center for Infectious Disease Research & Policy (CIDRAP)
Yohann Lacotte, Project Manager, EU-JAMRAI
Alan Laird, Director, Laboratory Services, Southwest Health System
James Lancaster, CEO, Solenic Medical
Elaine Larson, Senior Scholar in Residence, New York Academy of Medicine
Ramanan Laxminarayan, President & Founder, One Health Trust
Bruce Y. Lee, Executive Director, Public Health Computational and Operation Research (PHICOR), Senior Contributor, Forbes
Ofer Levy, Director, Precision Vaccines Program, Boston Children's Hospital Harvard Medical School
Benjamin Liu, Assistant Professor of Pediatrics & Pathology, Children’s National Hospital/George Washington Univ
Chelsea Luxen, Co-founder & CEO, ParaNano Wound Care, LLC
Syra Madad, Senior Director, System-wide Special Pathogens Program, NYC Health + Hospitals
Monica Magee, Project Firstline Infection Preventionist, Pennsylvania Department of Health
Jessica Malaty Rivera, Research Assistant, Johns Hopkins Center For Health Security
Apoorva Mandavilli, Health & Science Reporter, New York Times
Mary Manning Lou, Director, Jefferson Center for Infection Prevention and Antibiotic Stewardship
Kenneth Martinez, Chief Science Officer, IBEC
Anafi Mataka, Portifolio Lead, African Society For Laboratory Medicine
J. Scotch McClure, MBA, Chief Executive Officer, Maxwell Biosciences, Inc.
Anthony McDonnell, Senior Policy Analyst, Center for Global Development
Timothy Meehan, Senior Technical Advisor, Innovations and Commercialization, Clinton Health Access Initiative, Inc.
Timothy Meehan, Senior Laboratory Technical Advisor, Partnership for Supply Chain Management
Marc Meyer, Director of Pharmacy Services, Infection Control, Southwest Health System
Sheila Miknyoczki, Program Manager, BARDA
David Milestone, Senior Advisor, Co-Founder & Board Chair for AMP Health, McKinsey & Company
Mary Millard, Patient Advocate, Sepsis Survivor
Gareth Morgan, Head, Global Portfolio Management and AMR Policy., Shionogi Pharma
Jacob Morton, Global Program Director - Antimicrobial Stewardship, bioMérieux, Inc.
Mirfin Mpundu, Director, React Africa
Jomana Musmar, Executive Director, Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, DHHS
Windi Muziasari, Chief Executive Officer, Resistomap
Mohsen Naghavi, Professor, Director of Subnational Burden of Disease Estimation, Institute for Health Metrics and Evaluation (IHME)
Narayan Nair, Division Director for Division of Pharmacovigilance, Center for Biologics Evaluation and Research, U.S. Federal Drug Administration
Jonas Nguh, President - elect, Maryland Public Health Association
Brian Ngwatu, Senior Clinical Advisor, Clinton Health Access Initiative
Mr Paul Offit, Physician, Childrens Hospital of Pennsylvania
Lesley Ogilvie, Interim Secretariat Lead, Global AMR R&D Hub
Pascale Ondoa, Director of Science and New Initiatives, African Society For Laboratory Medicine
Assaf Oron, Chief Business Officer, Biomx
Kevin Outterson, Professor, Boston University, Executive Director, CARB-X
Lindsay Parish, Project Officer, BARDA
John Parkinson, Senior Editor, Contagion Live
Luna Parry, Regional Grants Coordinator, The Fleming Fund Management Agent
Deepali Patel, Director of International Policy, AMR Action Fund
Tom Patterson, Distinguished Professor of Psychiatry, University of California San Diego
Jonathan Pearce, Chief Executive Officer, Antibiotic Research UK
Meghan Pennini, Chief Therapeutics Officer, HCORE, HHS
Jessica Petrillo, Lead, Multilateral Affairs and Policy Team, USAID
Ann Marie Pettis, Former APIC President, Association for Professionals in Infection Control and Epidemiology
Wolfgang Philipp, Head of Unit, European Commission
Manise Pierre, Program Officer, American Society for Microbiology
Paul Plummer, Executive Director, National Institute of Antimicrobial Resistance Research and Education (NIAMRRE)
Nira Pollock, Associate Medical Director of the Infectious Diseases Diagnostic Laboratory, Boston Children's Hospital
Dave Powell, Chief Scientific Officer, LifeArc
Brittanii Prahl, Critical Care Clinical Pharmacist, Providence Regional Medical Center Everett
Lance Price, Professor and Director, Antibiotic Resistance Action Center, George Washington university
Robert Purdie, Program Coordinator, Valley Fever Institute
Robert Quigley, Co-Founder & Executive Chairman, International Corporate Health Leadership Council
Angela Rasmussen, Principal Research Scientist, VIDO
Rachel Rath, BARDA Alliance Director, Johnson & Johnson Innovation
Laurel Redding, Assistant Professor of Epidemiology, University of Pennsylvania
Kyu Y. Rhee, Professor of Medicine and Microbiology and Immunology, Weill Cornell Medicine
Tine Rikke Jorgensen, Technical Advisor Antimicrobial Resistance Unit, WHO EURO
Charlotte Robbins, Global Series Lead, BBC StoryWorks Programme Partnerships
David Robinson, Deputy Director, CMC Vaccine Development, Bill & Melinda Gates Foundation
Susan Rogers Van Katwyk, Managing Director, AMR Policy Accelerator
Nadine Rouphael, Executive Director - Hope Clinic, Emory University
Ed Rudnic, PhD, Chief Operating Officer and Head of R&D, Maxwell Biosciences, Inc.
Quaid Saeed, Chief Executive Officer, Islamabad Healthcare Regulatory Authority
Reynolds Salerno, Director, Division of Labratory Systems, CDC
Tharini Sathiamoorthy, Director of Health Policy, Cepheid
Souleymane Sawadogo, Chief Global Health Officer, Parsyl
Samuel Scarpino, Director of AI + Life Sciences, Northeastern university
Mary Schaheen, President, Prevail Partners Llc
Ted Schenkelberg, Senior Vice President and Chief Strategy Officer, The Human Immunome Project
Robert Schooley, Distinguished Professor of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego
Florence Sejourne, Chief Executive Officer, AUROBAC THERAPEUTICS
Diane Shader Smith, Independent Public Relations and Communications Professional, ---
Hui Shao, President and Chief Executive Officer, Yisheng Biopharma Co. Ltd.
Merewyn Sheeran, Project Firstline Infection Preventionist, Pennsylvania Department of Health
Fei Shen, Investment Director, Boehringer Ingelheim Venture Fund
Anita Sheoran, Program Manager, BARDA
Dawn Sievert, Senior Science Advisor, Antimicrobial Resistance Coordination & Strategy, Centers for Disease Control and Prevention
Alexandra Sifferlin, Health & Science Editor, The New York Times
Ruchika Singhal, President, Medtronic
Henry Skinner, Chief Executive Officer, AMR Action Fund
Robert Leo Skov, Scientific Director, International Centre for Antimicrobial Resistance Solutions
Subasree Srinivasan, Medical director, GARDP
Steffanie Strathdee, Co-Director, Center for Innovative Phage Applications & Therapeutics
Walter Straus, Vice President, Clinical Safety & Risk Management, Moderna Therapeutics
Edie Stringfellow, VP of Ecosystem Development, Center for Global Health Innovation
Amanda Stucke, Principal, Health Policy & Insights, Economist Impact
Terrence Stull, President, BacVax
Ashim Subedee, Director, Division of Research, Innovation, and Ventures (DRIVe) Catalyst Office, Biomedical Advanced Research and Development Authority (BARDA)
Ralf Sudbrak, Interim Secretariat lead, Global AMR R&D Hub
Casey Sullivan, Social Science Analyst, HHS
Anita Suresh, Head of Genomics and Sequencing Unit, FIND
Jessica Swenson, Program Analyst, HHS/ASPR/BARDA
Jill Taylor, Senior Advisor for Scientific Affairs, Association of Public Health Laboratories (APHL)
George Tetz, Chief Executive Officer, HUMAN MICROBIOLOGY INSTITUTE, INC.
Christopher Thomas, Medical Director: System Quality and Patient Safety, Our Lady of the Lake Regional Medical Center in Baton Rouge
Thomas Tillett, Chief Executive Officer, MBF Therapeutics
Janet Tobias, President & Founder, Global Health Reporting Center
Nikki Tyler, Director of partnerships, PEPFAR
Beatrice van der Puije, Portfolio Lead, African Society for Laboratory Medicine (ASLM)
Martijn van Gerven, Researcher, The Access to Medicine Foundation
Morgane Vanbiervliet, Manager, Market Intelligence & Business Development, Infectious Diseases, debiopharm international
Jay Varma, Professor and Director - Cornell Center for Pandemic Prevention & Response, Weill Cornell Medicine
Neil Vora, Pandemic Prevention Fellow, Conservation International
Katrine Wallace, Epidemiologist, University of Illlinois Chicago
David Wallinga, MD, Senior Health Officer, Natural Resources Defense Council
Brenda Waning, Chief, Global Drug Facility (GDF)
Margo Warren, Head of Policy, Access to Medicine Foundation
Collin Weinberger, Senior Advisor, Pandemics & Emerging Threats, US Department of Health and Human Services Office of Global Affairs
Matthew Wellington, Public Health Campaigns Director, Public Interest Research Group (PIRG)
Aaron Woodall, Chief, Tampa VA Infection Control Division
Adam Woodrow, President & Chief Commercial Officer, Paratek Pharmaceuticals , Inc.
Prashant Yadav, Senior Fellow, Center for Global Development
In-Kyu Yoon, Director & Global Head of Programmes and Innovative Technology, Coalition for Epidemic Preparedness Innovations
Kelly Zabriskie, Enterprise Vice President of Infection Control, Thomas Jefferson University
Rachel Zetts, Senior Officer, Antibiotic Resistance Project, The Pew Charitable Trusts
Shaohua Zhao, Senior Biomedical Researcher, FDA
Anne Zink, Chief Medical Officer for the State of Alaska & President of The Association of State and Territorial Health Officials, ASTHO, State of Alaska
Ghada Zoubiane, Head of Partnerships and Stakeholder Engagement, International Centre for AMR solutions (ICARS)
John Zurlo, Director - Division of Infectious Diseases, Thomas Jefferson University
GET INVOLVED AT THE
WORLD ANTI-MICROBIAL RESISTANCE CONGRESS
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events